Cost-effectiveness Analysis of Salmon Calcitonin and Zoledronic Acid in Treating Postmenopausal Osteoporosis
BAI Yao
ZHOU Xue-qin
LIU Yu-qin
Abstract：Objective To study the cost-effectiveness of calcitonin salmon and zoledronic acid in treating postmenopausal osteoporo-sis.Methods 126casesofpostmenopausalosteoporosiswerecollectedandrandomlydividedintotwogroups:groupAandgroupB.Data was evaluated using the cost-effectiveness analysis of pharmacoeconomics.Results The costs of group A and group B were 2 279.42 and 3 316.79 yuan respectively.The total effective rates of group A and group B were 57.14%and 79.37%respectively.Group B was higher than those in group A,and the difference was statistically significant in two groups (P<0.05).The cost-effectiveness ratios (C/E) of group A and group B were 39.89 and 41.78 respectively.Conclusion Group B has better compliance and is more reasonable as compared with group A.
Keywords：Salmon calcitoninZoledronic acidPostmenopausal osteoporosisCost-effectiveness analysis
Publication Date：2015-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：2( 301-302 )